This HTML5 document contains 137 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1038/
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q42606229
rdf:type
wikibase:Item
schema:description
мақолаи илмӣ บทความทางวิทยาศาสตร์ videnskabelig artikel artigo científico artículu científicu espublizáu en 2010 ১৪ ডিসেম্বর ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2010年論文 2010년 논문 vedecký článok bilimsel makale artikel ilmiah vědecký článek teaduslik artikkel επιστημονικό άρθρο articol științific artikull shkencor наукова стаття, опублікована в грудні 2010 artykuł naukowy 2010年論文 artigo científico научни чланак wissenschaftlicher Artikel wetenschappelijk artikel 2010年論文 2010年论文 artigo científico vetenskaplig artikel artículo científico publicado en 2010 2010年論文 научная статья scientific article published on 14 December 2010 2010年论文 article scientific vitskapeleg artikkel 2010年の論文 tieteellinen artikkeli 2010年论文 article científic tudományos cikk naučni članak 2010年論文 2010年论文 scienca artikolo scientific article published on 14 December 2010 articolo scientifico vitenskapelig artikkel научни чланак научна статия מאמר מדעי artikulong pang-agham bài báo khoa học 2010 nî lūn-bûn مقالة علمية نشرت في 14 ديسمبر 2010 2010年论文 2010年论文 article scientifique სამეცნიერო სტატია scientific article published on 14 December 2010
p:P577
wds:Q42606229-AEC26107-80DF-4BC1-882B-886CCA1CE14B
wdt:P577
2010-12-14T00:00:00Z
p:P407
wds:Q42606229-EFC3FFC7-81EB-456B-B243-CCE9D2F44A41
wdt:P407
wd:Q1860
p:P2888
wds:Q42606229-4C327E3C-64A7-437F-B754-C4F47D89E8FB
wdt:P2888
n10:sj.bjc.6606037
p:P2860
wds:Q42606229-935EBA91-E52D-4EF5-9B63-4A030CB0AFDF wds:Q42606229-9532582D-C28A-4BEE-9644-2A2CC172C911 wds:Q42606229-8BA1E176-EE32-4A1A-9CC5-3CCF18BD3253 wds:Q42606229-8D75D36B-9F58-44B2-9AD1-ECF6CFC39D2B wds:Q42606229-ACACCA6D-85B6-4D2D-9EF2-999A6CADD2E5 wds:Q42606229-99D622AC-BC43-430F-97D7-CC9CC31EF371 wds:Q42606229-9BC4DD01-7087-4E2C-8CF4-124DF86D2CBE wds:Q42606229-9DADD275-0E88-4F39-901B-6E843137D37A wds:Q42606229-C5AB1F85-4CCB-476A-9596-4FABDC715F7A wds:Q42606229-CDB8EEDE-E87F-42EF-BB5F-8930E636C87A wds:Q42606229-F43CA9A6-AFCB-44EB-9290-36B409694F0A wds:Q42606229-319F3BE3-D507-4552-BE74-01BB5D9715AA wds:Q42606229-414C1DB9-3E03-42D6-A7D2-CF91306B14F7 wds:Q42606229-2922853B-1320-40BE-A2D8-CC0D1F4002A7 wds:Q42606229-75330C16-6A84-4303-8E3D-141798256503 wds:Q42606229-80B4E1B4-E603-4239-97E9-D4847489FA37 wds:Q42606229-5C668E6C-EC7D-4423-8D3A-F808C13F70AE wds:Q42606229-6B16E1AC-E265-4863-BC28-875FD7A7CA13
wdt:P2860
wd:Q43872786 wd:Q52975855 wd:Q33847848 wd:Q36815525 wd:Q51927016 wd:Q36715251 wd:Q46726889 wd:Q51960759 wd:Q59566082 wd:Q36564213 wd:Q44747457 wd:Q34234498 wd:Q37721571 wd:Q37779999 wd:Q35113461 wd:Q36360632 wd:Q44058228 wd:Q74130382
p:P2093
wds:Q42606229-15C87C20-8845-4D0D-A501-EDF063EC49F6
wdt:P2093
M J Molina-Garrido
rdfs:label
Comment on 'capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer'. Comment on 'capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer'.
skos:prefLabel
Comment on 'capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer'. Comment on 'capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer'.
schema:name
Comment on 'capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer'. Comment on 'capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer'.
p:P50
wds:Q42606229-5B504542-796B-4EC1-A464-EF37D9E3BF68
wdt:P50
wd:Q57422009
p:P1476
wds:Q42606229-05D4E93F-4730-4FBB-B23A-0D7E6F68B77D
wdt:P1476
Comment on 'capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer'
p:P304
wds:Q42606229-9B62D1D4-0233-4AF5-90BD-FAE8C2B9C9C2
wdt:P304
224-5; author reply 226
p:P31
wds:Q42606229-7353C3D5-69D5-4FBA-837D-943492D3A471
wdt:P31
wd:Q13442814
p:P921
wds:Q42606229-BC7A673B-528D-499A-B9AC-20C341E50901 wds:Q42606229-928B94C8-C05B-4CD6-A1AE-167A2E62E653
wdt:P921
wd:Q413299 wd:Q188874
p:P698
wds:Q42606229-8BEC490B-0E2B-4961-9904-8B5F2E3672FF
wdtn:P698
n13:21157451
wdt:P698
21157451
p:P1433
wds:Q42606229-4C9595D4-CA11-4F50-B3F9-FEBA822EA979
wdt:P1433
wd:Q326309
p:P433
wds:Q42606229-5F43DF3C-94D6-4F84-A0B1-DAC868933E6E
p:P478
wds:Q42606229-DC409366-49AD-4786-93FB-C5BD4EB41D6D
wdt:P433
1
wdt:P478
104
p:P356
wds:Q42606229-88BB0A27-97AE-4922-B9D8-731E2C5D0FE9
wdtn:P356
n12:SJ.BJC.6606037
wdt:P356
10.1038/SJ.BJC.6606037
p:P5875
wds:Q42606229-71B119CB-4972-4929-8E6A-62AB4EFF8987
wdt:P5875
49682799
p:P932
wds:Q42606229-F62CC513-EA7C-46FA-800B-9624AB37BE0B
wdt:P932
3039811